No Pain, No Gain Crisis, Resilience, and Winning Trust from SARS to COVID-19 Response in Taiwan- Yi-Chun Lo, MD

APACC 2020

Maintaining epidemic control in Namibia: designing the optimal package - Lessons from ACS support to the Namibian Government

INTEREST 2020

Molecular epidemiology of Hepatitis C virus isolated from patients with newly diagnosed HCV infection in 2017-2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Mortality due to Hepatitis B and Hepatitis C - Findings from the Global Burden of Disease Study 2019 - Maegan Dirac

International Viral Hepatitis Elimination Meeting (IVHEM) 2020

Spontaneous HCV clearance in HCV/HIV coinfected patients from AIDS Center Prague- Viktor Aster

Central and Eastern European Meeting on Viral Hepatitis and HIV 2018

Peer Recruitment of Adolescent Girls and Young Women into A Biomedical HIV Prevention Study: Lessons from the Kampala Women’s Bone Study

International Workshop on HIV & Adolescence 2019

Latest findings from Zimbabwe’s ongoing STI etiology study - Kees Rietmeijer, PhD, MD, MSPH

INTEREST 2015

HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci

International Workshop on HBV Cure 2021

Debate: Can we eliminate HCV from Africa? (Not yet available)- Mark Nelson, MD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Eliminating Viral Hepatitis - Perspectives From (Some Members of) the South African Harm Reduction Community - Andrew Scheibe

International Viral Hepatitis Elimination Meeting (IVHEM) 2020